First Tracks Biotherapeutics (TRAX) PT Raised to $55 at Wells Fargo
Tweet
Share
E-mailGet Alerts TRAX Hot Sheet
Price: $45.50 +3.69%
Rating Summary:
9 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 9 | New: 24
Rating Summary:
9 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 9 | New: 24
Join SI Premium – FREE
Wells Fargo analyst Derek Archila raised the price target on First Tracks Biotherapeutics (NASDAQ: TRAX) to $55.00 (from $30.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Wolfe Research Starts First Tracks Biotherapeutics (TRAX) at Outperform
- Target (TGT) PT Raised to $185 at DA Davidson
- Kingsoft Cloud (KC) PT Raised to $17.70 at Jefferies
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
